This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Screening for neural tube defects

Authoring team

In 95% of cases of anencephaly or open meningomyelocoele, an increase in amniotic alpha-feto protein can be detected by the fifth month of pregnancy. Early termination can then be offered to the parents. False negatives occur in 0.5% of cases; false positives, in 2%. There is also an increase in amniotic acetylcholinesterase. High resolution ultrasound should be used to confirm the biochemical results.

Initially amniocentesis and estimation of alpha-feto protein was only considered in couples who had an affected child. However it has become apparent that maternal serum levels of alpha-feto protein are also raised in many cases of neural tube defect and screening of all mothers, irrespective of previous history may be undertaken.


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.